[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338581-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338581-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-mutations-rewire-the-rna-methylation-specificity-of-mettl3-mettl14-research-summary","Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14 - Research summary","","Chemical modifications of RNAs shape posttranscriptional gene regulation, and the METTL3-METTL14 complex controls most N6-methyladenosine (m6A) marks in messenger RNAs. Dysregulated methyltransferase activity is linked to cancers, yet how sequence context changes m6A placement remains unclear. The study shows a cancer-derived METTL14 gain-of-function mutation, METTL14R298P, increases malignant cell growth in culture and transgenic mice without raising global m6A levels. Instead, it preferentially methylates noncanonical GGAU motifs, generating m6A that is read by YTH proteins similarly to canonical sites but resisted from ALKBH5 demethylation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-mutations-rewire-the-rna-methylation-specificity-of-mettl3-mettl14-research-summary/338581/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-mutations-rewire-the-rna-methylation-specificity-of-mettl3-mettl14-research-summary/338581.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the role of the METTL3-METTL14 complex in RNA regulation?","Question",{"text":63,"@type":64},"METTL3-METTL14 generates most m6A modifications in messenger RNAs, which are important for posttranscriptional gene regulation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does METTL14R298P affect cancer-related cell behavior?",{"text":68,"@type":64},"METTL14R298P increases malignant cell growth in culture and in transgenic mice compared with wild type, demonstrating gain-of-function behavior.",{"name":70,"@type":61,"acceptedAnswer":71},"What distinguishes the mutation’s m6A specificity from canonical sites?",{"text":72,"@type":64},"The mutant preferentially methylates noncanonical GGAU-containing sites, producing m6A that is read by YTH readers similarly to canonical marks but is less efficiently removed by the demethylase ALKBH5.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338581,1790471498,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","CANCER  \nCancer mutations rewire the RNA methylation specificity of METTL3-METTL14  \nChi Zhang1, Robyn L. Scott1, Luiza Tunes1, Meng-Hsiung Hsieh2, Ping Wang1, Ashwani Kumar3, Brijesh B. Khadgi1, Yen-Yu Yang4, Katelyn A. Doxtader Lacy1, Emily Herrell1, Xunzhi Zhang3, Bret Evers5, Yinsheng Wang4, Chao Xing3, Hao Zhu2, Yunsun Nam1*  \nChemical modification of RNAs is important for posttranscriptional gene regulation. The METTL3-METTL14 complex generates most N6-methyladenosine (m6A) modifications in messenger RNAs (mRNAs), and dysregulated methyltransferase expression has been linked to cancers. Here we show that a changed sequence context for m6A can promote oncogenesis. A gain-of-function missense mutation from patients with cancer, METTL14R298P, increases malignant cell growth in culture and transgenic mice without increasing global m6A levels in mRNAs. The mutant methyltransferase preferentially modifies noncanonical sites containing a GGAU motif, in vitro and in vivo. The m6A in GGAU context is detected by theYTH family of readers similarly to the canonical sites but is demethylated less efficiently by an eraser, ALKBH5. Combining the biochemical and structural data, we provide a model for how the cognate RNA sequences are selected for methylation by METTL3-METTL14. Our work highlights that sequence-specific m6A deposition is important and that increased GGAU methylation can promote oncogenesis.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. Distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nSpecific and controlled modification of mRNAs with N6-methyladenosine (m6A) is essential for proper gene expression ( 1, 2) . METTL3 and METTL14 form a heterodimeric methyltransferase responsible for most m6A modifications in mRNAs (3–5) . Dysregulated expression of METTL3 or METTL14 affects mRNAm6A modification levels (3, 6) . Several cancers have been linked to METTL3-METTL14 overexpression and increased global m6A levels in mRNAs, but the molecular mechanism is complex and context dependent (7–9) . Transcriptome-wide mapping of m6A sites affected by METTL3-METTL14 has shown that the preferred RNA targets of METTL3-METTL14 contain the motif DRACH (D, G/A/U; R, G/A; H, A/U/C), with a dominant Cyt following the methylated Ade (10–13) . However, how the major m6A writer complex recognizes the preferred target RNA sequence is still not understood. Furthermore, the biological and molecular consequence of changing the substrate preference is yet unknown.  \nIn METTL14, R298 is the most frequently mutated residue in samples from patients with cancer, and the mutant allele is observed along with the wild type (WT) (fig. S1, A and B) ( 14) . Previous studies proposed that lower activity or aberrant specificity of the METTL14R298P mutant leads to loss of canonical m6A and the associated effects (7, 15). However, the potential gain of function (GOF) of the cancer mutation has not been described. A novel function for the mutation would explain the observed enrichment of cancer mutations of METTL14R298 . Here, we show that R298P in METTL14 is a GOF mutation that promotes oncogenic cell growth compared to WT orthe D312A loss-of-function (LOF) mutant. R298 mutants gain  \n1Department of Biochemistry, Department of Biophysics, Simmons comprehensive cancer center, University of texas Southwestern Medical center, Dallas, tX 75390, USA. 2children’s Research institute, Departments of Pediatrics and internal Medicine, center for Regenerative Science and Medicine, University of texas Southwestern Medical center, Dallas, tX 75390, USA. 3eugene McDermott center for human Growth and Development, Department of Bioinformatics, University of texas Southwestern Medical center, Dallas, tX 75390, USA. 4Department of chemistry, University of california at Riverside, Riverside, cA 92521, USA. 5","cbCaigQWBu8nDMeh","https://ap.wps.com/l/cbCaigQWBu8nDMeh","pdf",4700751,16,"English","# Introduction\n## m6A writers and sequence preference\n## METTL14 R298 mutation and hypotheses\n# Results\n## METTL14R298P promotes malignant growth","[{\"question\":\"What is the role of the METTL3-METTL14 complex in RNA regulation?\",\"answer\":\"METTL3-METTL14 generates most m6A modifications in messenger RNAs, which are important for posttranscriptional gene regulation.\"},{\"question\":\"How does METTL14R298P affect cancer-related cell behavior?\",\"answer\":\"METTL14R298P increases malignant cell growth in culture and in transgenic mice compared with wild type, demonstrating gain-of-function behavior.\"},{\"question\":\"What distinguishes the mutation’s m6A specificity from canonical sites?\",\"answer\":\"The mutant preferentially methylates noncanonical GGAU-containing sites, producing m6A that is read by YTH readers similarly to canonical marks but is less efficiently removed by the demethylase ALKBH5.\"}]","Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14 - Research summary | PDF",1790024343,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79466ed70bfa692d6bcebb891c7e3e11.webp",983,1250,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2682465285a272478f5f0d0ebe8a248.webp",982,1249,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea94b5fd0d6c66dd86e02695a791cf3e.webp",981,1248,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a04065431a0c4e88510048ea89bde17.webp",980,1247]